Shanghai Fosun Pharmaceutical (Group) Co., Ltd. — SEC Form 4 filings

SEC reporting owner CIK 1615258. 3 Form 4 filings on record with FilingPulse; latest filed 2025-06-27.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-10-15 to 2025-06-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NATURES SUNSHINE PRODUCTS INC (NATR)10% owner38 legs · 2,867,802 sh · $32,888,9311

Form 4 filings — Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

FiledFormIssuerReported transactionsSource
2025-06-274NATURES SUNSHINE PRODUCTS INC (NATR)
jointly with Fosun Pharma USA Inc.
Sale (S): 2,854,607 @ $11.46EDGAR
2024-10-174NATURES SUNSHINE PRODUCTS INC (NATR)Sale (S): 2,300 @ $13.02EDGAR
2024-10-154NATURES SUNSHINE PRODUCTS INC (NATR)Other (J): 2,968 @ $0 · Sale (S): 1,399 @ $13.54 · Sale (S): 1,800 @ $13.13 · Sale (S): 1,816 @ $13.36 · Sale (S): 3,000 @ $13.39 · Sale (S): 1,580 @ $13.37 · +1 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1615258 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →